Grammy-winning soul vocalist D’Angelo died on October 14 at age 51 after a personal fight with pancreatic cancer.
“The shining star of our household has dimmed his light for us in this life,” his relatives confirmed. “After a lengthy and brave struggle with the disease, we are heartbroken to announce that D’Angelo, known to his followers around the globe as D’Angelo, has been taken from us.”
D’Angelo made a lasting impact on the music industry with his innovative neo-soul sound and partnerships with high-profile artists.
He released his first record, “Brown Sugar,” in 1995 to instant praise. The record achieved the fourth spot on Billboard’s Top R&B Albums chart, went platinum soon after, and earned several Grammy nominations.
However, it was his sophomore release, “Voodoo,” in the year 2000 that propelled his music career into the stratosphere. The record premiered at No. 1 on each of Billboard’s Top R&B Albums chart and the main album chart. He received two Grammy Awards: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”
The music video for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The personal depiction featured the artist, famously stripped down to his waist, performing directly into the camera.
D’Angelo retreated from the public eye after putting out Voodoo and publicly struggled with drugs and alcohol. In 2005, he was part of a severe car crash that left him in grave health.
Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with a further top chart entry on the soul music rankings and a award for Top R&B Record.
Once more, in his own mysterious way, D’Angelo made only a few public appearances in the following years.
The musician was scheduled as a headliner for the 2025 music event, but his appearance was called off, citing an “unexpected health issue.”
Although information is limited about D’Angelo’s well-being in the months leading up to his death, he had apparently been hospitalized for an extended period and in palliative care for a fortnight.
D’Angelo’s demise is a stark reminder of the devastating effects of pancreatic cancer, one of the most deadly and least preventable types of the illness, on a brilliant talent whose life was cut short.
“We are grieved that he can only provide cherished moments with his family, but we are eternally grateful for the legacy of extraordinarily moving music he has left us,” his kin said.
Pancreatic malignancy impacts the pancreas, a small organ that generates the hormone insulin and is vital in breaking down food, among other functions. The size and location of the pancreas in the human system make it more difficult to identify cancer.
Although pancreatic cancer makes up only approximately three percent of cancer diagnoses annually in the U.S., it is causes 7% of cancer deaths.
Nearly 70,000 people will be diagnosed with this condition and about fifty-two thousand will die of the disease in the year 2025.
“This malignancy is one of the deadliest cancers, with an aggressive tumor and dismal outcomes. We have few and poor treatment options, and a narrow opportunity to make a meaningful impact on the well-being of patients,” said a cancer specialist.
Because pancreatic cancer seldom produces early symptoms, it’s often identified only once the condition is late-stage. Even when a individual has symptoms they are often vague and may be mistaken for a several common illnesses.
“As of yet, there is no effective method to detect pancreatic cancer in the initial phases, except for listening to your body and speaking with your doctor if there are unfamiliar symptoms,” explained a medical director.
Common symptoms of pancreatic cancer encompass:
At age 51, D’Angelo’s demise is an outlier, as this malignancy is most common in adults in the sixty-five to seventy-five range. However, many cancers, including this type, have become increasingly prevalent among younger adults.
“Pancreatic cancer diagnosed before the age of 50 is considered rare, yet concerningly, doctors are noticing a growing number of younger patients affected by this condition,” said a specialist.
In the absence of effective screening tools for pancreatic cancer, experts stressed the significance of understanding your relatives’ cancer history. Certain contributing elements, such as smoking and excess weight also play a role in the onset of pancreatic cancer.
Black individuals have the greatest occurrence of pancreatic cancer in the U.S. and are more prone to be diagnosed with inoperable cancer.
“The first step toward lowering one’s chance of this condition is understanding individual susceptibility. People should review their family history, hereditary factors, and medical conditions, such as blood sugar disease, chronic pancreatitis, or overweight that may raise their vulnerability,” advised a medical professional.
Hereditary risk factors are associated with as much as 10% of all this malignancy cases. If a relative in your family has had this disease, you may want to consider genetic testing.
“For individuals with a relative’s background of this condition or those having elevated risk genetic mutations, screening may involve advanced imaging such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to detect early changes in the pancreas,” he clarified.
For those looking to reduce their risk, lifestyle changes may have an effect. The best step you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you don’t smoke, stay away altogether.
Heavy drinking is associated with pancreatitis, a contributing element for pancreatic cancer, so reducing or avoiding alcohol may assist lower your chance.
Managing your weight or shedding pounds may also help reduce your risk. Individuals with excess weight are 20% more likely to get pancreatic cancer. This malignancy also occurs more often in people with blood sugar issues, and weight loss can also lower the risk of type 2 diabetes.
In spite of this disease’s grim outlook, there is reason for optimism.
“We are doing better with treatments and newer mixed drug treatments. There are developing precision medicines that already are making an impact,” said a specialist.
For many people, however, education about this rare but {dev
A tech strategist with over a decade of experience in digital innovation and AI-driven solutions, passionate about shaping the future of technology.